Diet and fasting combo shows promise for Alzheimer's patients

NCT ID NCT06898424

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study looked at whether a plant-based ketogenic diet combined with intermittent fasting (called Ketoflex 12/3) could slow the progression of early-to-mid stage Alzheimer's disease. Sixty participants followed the diet, and researchers measured changes in memory and thinking using a standard test. The goal was to see if this dietary approach could help control the disease and improve cognitive function.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ALZHEIMER TYPE DEMENTIA are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

Alzheimer disease Cognitive Dysfunction Intermittent Fasting Nerve Degeneration

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Istanbul Medipol Universitesi

    Istanbul, 34214, Turkey (Türkiye)

More trials for these conditions

Other studies related to the condition(s) this trial covers.